Vestibular Infants Screening-Flanders

Summary

Hearing-impaired children are at risk for a vestibular impairment, as the auditory and vestibular end organs are closely related. Although this can compromise a child's development on many levels, vestibular testing is not routinely performed in this vulnerable group. This project aims to give each congenitally hearing-impaired child in Flanders (Belgium) access to a basic vestibular screening at a young age and set an example for other regions worldwide.

Conditions

• Vestibular Disorder
• Hearing Impaired Children

Interventions

DIAGNOSTIC_TEST

cervical vestibular evoked myogenic potentials (cVEMP)

cVEMPs are ipsilateral, short latency, inhibitory myogenic potentials that assess otolith (mainly saccular) function and the integrity of the inferior branch of the vestibular nerve.

Sponsors & Collaborators

• Universitair Ziekenhuis Brussel

  collaborator OTHER

• Universitaire Ziekenhuizen KU Leuven

  collaborator OTHER

• Cliniques universitaires Saint-Luc- Université Catholique de Louvain

  collaborator OTHER

• Queen Fabiola Children's University Hospital

  collaborator OTHER

• AZ Turnhout

  collaborator OTHER

• Gasthuis Zusters Antwerpen

  collaborator OTHER

• GZA Ziekenhuizen Campus Sint-Augustinus

  collaborator OTHER

• University Hospital, Antwerp

  collaborator OTHER

• Jessa Hospital

  collaborator OTHER

• Ziekenhuis Oost-Limburg

  collaborator OTHER

• Algemeen Stedelijk Ziekenhuis

  collaborator OTHER

• Algemeen Ziekenhuis Maria Middelares

  collaborator OTHER

• AZ Delta

  collaborator OTHER

• AZ Sint-Jan AV

  collaborator OTHER

• AZ Sint-Lucas Brugge

  collaborator OTHER

• Sint-Lievenspoort Gent

  collaborator UNKNOWN

• Center for Developmental and Hearing Disorders

  collaborator UNKNOWN

• University Hospital, Ghent

  lead OTHER

Principal Investigators

• Leen Maes, Prof. Dr. · University Ghent

• Ingeborg Dhooge, Prof. Dr. · University Hospital, Ghent

Study Design

Allocation

NA

Purpose

DIAGNOSTIC

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

4 Months

Max Age

24 Months

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2018-06-01

Primary Completion

2021-07-01

Completion

2022-08-11

Countries

• Belgium

Study Locations